Activation of the NF-κB and MAPK signaling axes via the MyD88 pathway (137) promotes dendritic cell (DC) maturation and antigen presentation function, laying the foundation for enhancing anti-tumor immune responses. Here, NFKB1 is linked to neoplasm.